Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cefdinir vs Amoxicillin/Clavulanate in Pediatric Acute Otitis Media
NCT00644943Phase 4Completed
- Sponsor
- Abbott Laboratories
- Start
- Feb 2003
- Primary completion
- Apr 2003
- Modality
- Reversible Covalent Inhibitors
- Countries
- 1
01
Overview
A Phase 4 trial of cefdinir in acute otitis media (AOM), sponsored by Abbott Laboratories. Started Feb 2003; status: completed.
02
Drugs
cefdinir
03
Conditions
acute otitis media (AOM)
Beyond the preview
Go deeper on NCT00644943.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00644943.